SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS
Clinical safety rating: caution
Comprehensive clinical and safety monograph for SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS (SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS).
Topical barrier cream that physically adsorbs and neutralizes chemical warfare agents (e.g., sulfur mustard, soman, VX) via reactive chemistry within its matrix, reducing skin absorption and systemic toxicity.
| Metabolism | Not metabolized; acts as a topical barrier. Systemic absorption is negligible under intended use conditions. |
| Excretion | Renal: <1% unchanged; biliary/fecal: minimal; primarily remains on skin surface and is removed via washing or natural desquamation; systemic absorption is negligible (<0.1%). |
| Half-life | Not applicable; no systemic half-life due to lack of significant absorption; topical residence half-life on skin is approximately 4-6 hours before removal by washing or sloughing. |
| Protein binding | Not applicable; negligible systemic absorption; no protein binding data available. |
| Volume of Distribution | Not applicable; no systemic distribution; estimated Vd is 0 L/kg due to lack of absorption. |
| Bioavailability | Topical: 0% systemic bioavailability; acts as a non-absorbed barrier. |
| Onset of Action | Topical: Immediate upon application (seconds to minutes) as a physical barrier; no systemic onset. |
| Duration of Action | Topical: Up to 6-8 hours with single application, depending on exposure conditions; reapplication recommended after heavy sweating, washing, or 6 hours. |
Topical: Apply a thin layer (approximately 1-2 mm) to exposed skin, covering all at-risk areas, typically once before expected exposure; reapply after 4 hours if exposure continues or after decontamination. Not for ingestion or injection.
| Dosage form | PASTE |
| Renal impairment | No specific dose adjustment required for renal impairment as systemic absorption is negligible (topical application only). |
| Liver impairment | No specific dose adjustment required for hepatic impairment as systemic absorption is negligible (topical application only). |
| Pediatric use | Weight-based: Apply thin layer (approximately 0.5-1 mm) to cover all at-risk skin areas; adjust amount proportionally to body surface area. Use same frequency as adults (once before exposure; reapply after 4 hours if needed). |
| Geriatric use | No specific dose adjustment required; apply thin layer (1-2 mm) to intact skin as in adults. Monitor for skin irritation due to thinner skin in elderly; avoid application to broken skin. |
| 1st trimester | Consult provider |
| 2nd trimester | Consult provider |
| 3rd trimester | Consult provider |
Clinical note
Comprehensive clinical and safety monograph for SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS (SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS).
| Breastfeeding | No systemic absorption; M/P ratio not applicable. Compatible with breastfeeding. |
| Teratogenic Risk | No systemic absorption; direct fetal exposure negligible. Not teratogenic. |
| Fetal Monitoring | None required; skin exposure only. |
■ FDA Black Box Warning
None
| Common Effects | Application site reactions burning irritation itching and redness |
| Serious Effects |
Hypersensitivity to any component (e.g., perfluorocarbons, silicones). Do not apply to eyes or mucosal surfaces.
| Precautions | Not a substitute for immediate decontamination; remove contaminated clothing and wash skin with soap and water after exposure. Avoid eye contact. In case of eye exposure, flush with water for 15 minutes. Do not use on open wounds or burned skin. Efficacy may be reduced with heavy sweating or prolonged exposure. |
Loading safety data…
| Fertility Effects | No systemic absorption; no effect on fertility. |